In the last two years the research questions have shifted: not whether CK rises after a match, but how long it stays up under a congested calendar, why two players with the same workload show very different values, whether CK can flag injury risk at all, and where the line runs between normal post-match elevation and exertional rhabdomyolysis. This review gathers peer-reviewed studies published in 2025 and 2026 together with public reports from clubs, federations and hospitals, and updates our May 2026 article on biomarkers for load monitoring.
Section 01Where we left off: the May 2026 article
In May 2026 we published Objective assessment of athlete readiness: biomarkers for load monitoring and injury-risk reduction. Its three central points still hold:
- CK, together with AST, LDH and creatinine, reflects the degree of muscle fibre microtrauma after competition far more strongly than after training, and recovery to baseline may take several days.
- CK must be read against each athlete's own baseline, not a laboratory reference range: 500 U/L can be routine for one player and a warning for another.
- CK alone does not predict future muscle injury. In a four-season cohort at a professional club (1,656 samples), CK on the second day after a match had a sensitivity of about 56% and a specificity of about 55% for subsequent muscle injury.

